These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24976475)

  • 21. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS; Lip GY
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke prevention in atrial fibrillation: impact of novel oral anticoagulants.
    Haft JI
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):241-8. PubMed ID: 22952215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study.
    Monz BU; Connolly SJ; Korhonen M; Noack H; Pooley J
    Int J Cardiol; 2013 Oct; 168(3):2540-7. PubMed ID: 23664436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation therapy for atrial fibrillation.
    Hylek EM
    Semin Thromb Hemost; 2013 Mar; 39(2):147-52. PubMed ID: 23397554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New anticoagulants for the prevention of stroke in atrial fibrillation.
    Höchtl T; Huber K
    Fundam Clin Pharmacol; 2012 Feb; 26(1):47-53. PubMed ID: 21883447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prevention in atrial fibrillation: do we still need warfarin?
    Diener HC; Weber R; Lip GY; Hohnloser SH
    Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial Fibrillation and Stroke: Making Sense of Recent Observations on Anticoagulation.
    Proietti M; Lip GY
    Cardiol Clin; 2016 May; 34(2):317-28. PubMed ID: 27150180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New avenues for anticoagulation in atrial fibrillation.
    Mantha S; Cabral K; Ansell J
    Clin Pharmacol Ther; 2013 Jan; 93(1):68-77. PubMed ID: 23212107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
    Han J; Cheng J; Mathuria N
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.
    Alberts MJ; Eikelboom JW; Hankey GJ
    Lancet Neurol; 2012 Dec; 11(12):1066-81. PubMed ID: 23153406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
    Martínez-Rubio A; Dan GA; Kaski JC
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.
    Deitelzweig S
    Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
    Kasmeridis C; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
    Blanco-Molina A
    Rev Clin Esp; 2012 Jan; 212 Suppl 1():3-7. PubMed ID: 23117646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation.
    Wisler JW; Becker RC
    Crit Pathw Cardiol; 2012 Jun; 11(2):55-61. PubMed ID: 22595815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Yates SW
    Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.